The fiscal 2007 defense authorization act includes a provision to prevent the Defense Department from increasing Tricare beneficiary costs such as Tricare Prime or Tricare Standard fees, Tricare Reserve Select premiums, or pharmacy copays. The ban, however, would apply only to fiscal 2007. The act also cancelled an earlier effort to require use of the TMOP (Tricare mail order pharmacy) for refills of maintenance drugs. In addition, it did not include previous plans to eliminate copays for drugs ordered through the TMOP and to require drug suppliers to give retail pharmacies price discounts similar to those given to the TMOP system.